Opinion | A Brutal Disease, Gene Therapy and a Chance to Undo Past Wrongs
A decision by the F.D.A. this week could change care for thousands of Americans living with sickle cell.
Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A decision by the F.D.A. this week could change care for thousands of Americans living with sickle cell.
FDA soon rules if gene-editing CRISPR drug Exa-cel can be used commercially to treat sickle cell disease, opening door to many other therapies.
The recent publication in Science by Mogila, Tamulaitiene et al. represents a continuation of the successful scientific research conducted by Gintautas Tamulaitis' group.
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. Our episode is live! Episode Description We begin this episode by discussing our article of the week from the New England
Jennifer Doudna answers our questions.